Persistent pulmonary hypertension and prostaglandin D2.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004345:Drug Industry; D005260:Female; D005311:Fetal Hypoxia / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D015230:Prostaglandin D2; D011453:Prostaglandins / Q000627:therapeutic use*; D011457:Prostaglandins D / Q000494:pharmacology / Q000627:therapeutic use*; D014043:Tolazoline / Q000627:therapeutic use
D011453:Prostaglandins; D011457:Prostaglandins D; D014043:Tolazoline; D015230:Prostaglandin D2